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Bovine seminal ribonuclease, a uniquely drmeric pancreatic-like RNase, with its dimeric structure stabilized by two intersubunit disulfides, and 
endowed with special, i.e. non-catalytic, actions (antitumor, immunosupp~sive, antispe~atogenic), was stably expressed in Chinese hamster ovary 
cells. The r~mbinant protein, secreted in the culture medium as a correctly folded dimeric enzyme, was purified to homogeneity and found to 
be fully active both in its catalytic and antitumor activities. 
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1. INTRODUCTION 
The interest in bovine seminal ribonuclease (BS- 
RNase) arises from its very characteristic structure, and 
its catalytic and special (i.e. non-catalytic) biological 
actions ([l] and references cited therein). BS-RNase is 
in fact the only dimeric member of the pancreatic-like 
RNase superfamily [2], with a dimeric structure main- 
tained also by intersubunit disulfides. As for its func- 
tional properties, it is the only RNase with allosteric 
properties, and it is also an antitumor, an antispermato- 
genie and an immunosuppressive factor [l]. The many 
questions on the structural and functional features of 
BS-RNase, such as the molecular basis of its allosteric 
properties, and of its multiform non-catalytic actions, 
have been addressed so far by classical protein chemis- 
try methodologies 13-51. A different, potentially much 
more productive approach, would be that of engineer- 
ing BS-RNase through appropriate site-directed or re- 
gional mutagenesis of the DNA coding for the protein 
chain. This approach may shed light on the structural 
determinants underlying the biological actions of the 
enzyme, and may direct towards the preparation of bio- 
technologically interesting protein derivatives. 
An essential and crucial step in protein engineering 
is the expression in suitable systems of the DNA coding 
for the protein. This step, already proven to be difficult 
for ribonucleases in general, probably due to the cellular 
toxicity of these enzymes, can be even more exacting in 
the case of BS-RNase, due to some of the structural 
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features of the enzyme, such as the disul~de-maintained 
dimeric structure. 
We report here the expression in a eukaryotic system, 
consisting of Chinese hamster ovary cells, of BS-RNase 
as a dimeric protein, fully active in its catalytic and 
antitumor activities. 
2. MATERIALS AND METHODS 
2.1. Gene& procedures 
Bacterial cultures, plasmid purification, restriction endonuclease 
digestions, DNA ligations and bacterial transformations were per- 
formed according to Sambrook et al. [6]. Vectors were propagated in 
Escherichuz co11 strain JM 101 (Boehringer). DNA fragments were 
eluted from agarose gels with the Gene-Clean Kit (Bio 101). Double- 
strand DNA was sequenced using the Sequenase Sequencing Kit (US 
Biochemrcals Corporation). Polyacrylamide gel electrophoresis m so- 
dium dodecyl sulfate (SDS-PAGE) was carried out according to 
Laemmli 171. After electrophoresis, the gels were stained for protein 
detection with Coomassie blue, or stained for RNase activity [8], or 
blotted on nitrocellulose for immunostaining, carried out as previ- 
ously described [9]. RNase activity was assayed with minor modifica- 
tions of a previously reported method [lo]. Amino acid sequence 
determmations were carried out on the Applied Biosystems equencer 
473A. 
2.2. Construction of the expression vector 
The strategy employed for constructing the expression vector is 
illustrated m Fig. 1. The semi-s~thetic DNA coding for BS-RNase 
subunit chain, cloned in plasmid pMC-P-BS (de Nigris et al., manu- 
script in preparation), was removed from the vector by digestion with 
EcoRI and Sun (Promega Biotech), and extended at its 5’ end by 
addition of 94 bp of synthetic DNA. This extension coded for the 
signal sequence (residue -26 to -1) as deduced from the cDNA se- 
quence of the BS-RNase precursor [l 11, and contained an upstream 
BarnHI site. The addition was performed by a novel procedure based 
on the polymerase chain reaction (manuscript in preparation). 
The expression vector was constructed from the pLEN-ACEVII 
vector, kindly provided by M.R.W. Ehlers (Harvard Medical School, 
Boston, MA. USA), and based on the eukaryottc expression vector 
pMThGHSV402, equipped with the inducible metallothionein IlA 
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promoter, as prepared by Friedman et al. [12]. pLEN-ACEVII con- 
tained the SV40 splice sites and polyadenylation signals, and the cod- 
ing sequence of the angiotensin-converting enzyme [131. The latter was 
removed through digestion with ~~HI/~~~ and replaced with the 
extended cDNA described above, coding for pre-BS-RNase, and 
trimmed by digestion with BanrHI and S&I. Sequence analyses of the 
resulting recombinant vector, denominated pMC-E-BS, revealed that 
it contained the expected sequence of BS-RNase cDNA, including the 
upstream leader sequence. 
2.3. Transfection and cell cultures 
The recipient cells were Chinese hamster ovary cells, CHO Kl, 
provided by ATCC, Rockville, MD, USA. They were propagated and 
cotransfected as described [131 with the pMC-E-BS vector f 16 pg per 
100 mm plate) as well as with the pSV2NEO vector (2 pug per plate), 
inducing resistance to the neomycin analog G418 (Gibco). After selec- 
tion for resistance to G418, stable transformants were individually 
retrieved, subcultured in 24-well plates, and induced with 40 ,uM zinc 
sulphate in the presence of 0.5% serum. Culture medium from each 
clone was then tested by an ELISA assay [14] using anti-BS-RNase 
polyclonal antibodies prepared as described [9]. Preparative induc- 
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Fig. 1. Strategy for the construction of vector pMC-E-BS for expres- 
sion of recombinant bovine seminal RNase. 
tions of selected clones were performed in 150 mm plates, replacing 
the medium every 2-3 days. 
3. RESULTS AND DISCUSSION 
The clone expressing the highest level of BS-RNase- 
like immunoreactivity (0.4 pg/ml on the basis of ELISA 
assays) was propagated and found to be stable through 
ten population doublings in the absence of the selecting 
agent G418. 
Medium from induced cultures (2 1) was concentrated 
IO-fold by ultrafiltration on an Amicon concentrator 
equipped with YM3 membranes. The concentrated ma- 
terial was dialyzed against 40 mM T&-Cl, pH 7.4, clar- 
ified by centrifugation, and loaded on a heparin-agarose 
column (1.4 x 4 cm) equilibrated in the same buffer. The 
column, washed with the equilibrating buffer contain- 
ing 50 mM NaCl, was eluted with 0.1 M Tris-Cl, pH 8, 
containing 0.4 M NaCi. The eluate was diluted 1:2 with 
NaCl-free buffer and Ioaded on a Mono-S column 
equilibrated with the same buffer containing 0.2 M 
NaCl. After a 30-min wash with this buffer, the NaCl 
concentration was raised to 0.24 M, and after 35 min 
to 0.4 M. This eluted a single peak of RNase activity, 
with a 32% final yield with respect o the original culture 
medium. The protein, desalted and concentrated by cen- 
trifugation on a Centricon concentrator, was found to 
have a specific activity identical to that of BS-RNase 
isolated from bovine seminal vesicles. 
As shown in Fig. 2, upon SDS-PAGE under non- 
reducing conditions a single band was detected, comi- 
grating with BS-RNase isolated from seminal vesicles. 
On gels run in parallel the protein band was found to 
stain for RNase activity, and after blotting on a nitro- 
cellulose membrane, to react with anti-BS-RNase anti- 
bodies. When SDS-PAGE was performed under reduc- 
ing conditions in 0.1% 2-mercaptoethanol, the recombi- 
nant protein was found to run with the molecular size 
of BS-RNase monomers (see Fig. 2). 





Fig. 2. Polyacrylamide gel electrophoresis n sodium dodecyl sulfate 
in the presence (lanes 3 and 4), and in the absence (all other lanes) of 
2-mercaptoethanol. Lanes I, 3, 5 and 7: BS-RNase isolated from 
seminal vesicles; lanes 2, 4, 6 and 8: recombinant BS-RNase. Lanes 
1 through 4 were stained with Coomassie blue; lanes 5 and 6 were 
stamed for RNase activity; lanes 7 and 8 were from an immunoblot 
treated with anti-BS-RNase antibodies. 
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Fig. 3. Ion exchange chromatography of recombinant BS-RNase on 
a Mono S column eluted with a salt gradient for detection of isoen- 
zymic subforms a2, cc/3 and /$. 
(i) was immunologically indistinguishable from BS- 
RNase; (ii) had the same molecular size as BS-RNase, 
and (iii) was a dimeric protein, with a dimeric structure 
stabilized by intersubunit disulfides, as in natural BS- 
RNase. 
Sequence analyses of the recombinant protein re- 
vealed that its N-terminal sequence (residues I-18) was 
identical to the sequence of BS-RNase [15], indicating 
a correct proteolytic cleavage of the signal sequence. 
Furthermore, when analyzed by ion exchange chroma- 
tography for the detection of isoenzymic forms [ 161, the 
protein separated into three components (see Fig. 3) 
presenting the characteristic pattern of native BS- 
RNase. It has been established that the three compo- 
nents correspond to isozymes Q, @I and P2, as gener- 
ated from the nascent /I2 form by selective deamidation 
of Asn6’ in one or both p subunits [16]. This event 
occurs in vivo during the storage of the protein in sem- 
inal vesicles [17]; apparently, rBS-RNase undergoes in 
the culture medium the same selective deamidation 
processes which occur to BS-RNase stored in the secre- 
tion of seminal vesicles. 
Finally, rBS-RNase was tested as previously de- 
scribed [3] for one of the characteristic non-catalytic 
biological actions of BS-RNase, its antitumor action. 
Mouse 3T3 fibroblasts, transformed with SV40 virus, 
and the non-transformed parental line, were cultured 
for 48 h in the presence of 50 &ml recombinant en- 
zyme, rBS-RNase was found to inhibit the growth of 
transformed cells by more than 70%, just like natural 
BS-RNase, whereas the non-transformed cells were un- 
affected by the enzyme treatment. 
In conclusion, the data reported above show that 
CHO cells transfected with pMC-E-BS expression vec- 
tor are an effective and convenient system for the pro- 
duction and secretion in the culture medium of a cor- 
rectly processed rBS-RNase. The secreted enzyme can 
be purified with a simple 2-step procedure, and is indis- 
tinguishable in its structure and activity from the en- 
zyme as isolated from its natural source. 
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